Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 6180 of 20,252 grants

Active NON-SBIR/STTR RPGS
Virtual Mindful After Cancer Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors
NATIONAL CANCER INSTITUTE Oregon State University United States 2024 – 2027

PROJECT SUMMARY Sexual concerns are among the most common, distressing, and persistent aspects of life after cancer. For at least half of breast and gynecological cancer survivors,...

$3.19M
USD
Active NON-SBIR/STTR RPGS
Investigating Feasibility and Acceptability of the FearLess Protocol for Patients with Primary Malignant Brain Tumors and Their Caregivers
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2024 – 2027

PROJECT SUMMARY / ABSTRACT Fear of cancer recurrence (FCR) is alarmingly high among patients with primary malignant brain tumors, who face the certainty of tumor recurrence given t...

$2.89M
USD
Active NON-SBIR/STTR RPGS
Genetically-encoded molecular imaging of genome-edited immune cells
NATIONAL CANCER INSTITUTE University of Cincinnati United States 2024 – 2029

Project Summary Adoptive cell transfers constitute a new paradigm in cell-based therapeutics with wide-ranging applications from neurodegenerative, cardiovascular, autoimmune disor...

$4.98M
USD
Active NON-SBIR/STTR RPGS
Enhancing radioligand therapy for prostate cancer with biomarker and dosimetry guided personalization
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2029

ABSTRACT Radiopharmaceutical therapy (RPT) that delivers targeted cytotoxic radiation to cancer cells is typically administered on a fixed activity basis, without personalization,...

$6.45M
USD
Active NON-SBIR/STTR RPGS
A liver digital twin for personalized cancer therapy
NATIONAL CANCER INSTITUTE University of California At Davis United States 2024 – 2027

Project Summary/ Abstract Our long-term objective is to improve the efficacy and safety of liver cancer transarterial embolization through new computational tools that enable the d...

$3.58M
USD
Active SBIR-STTR RPGS
Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA
NATIONAL CANCER INSTITUTE Binary Genomics, Inc United States 2024 – 2026

ABSTRACT: Immunotherapies produce remarkable, long-term responses in subsets of patients with non-small cell lung cancer, but unfortunately, most patients do not respond to such tr...

$9.91M
USD
Active NON-SBIR/STTR RPGS
Assessment of germline variants associated with immune-related adverse events following immune checkpoint inhibitors
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2029

PROJECT SUMMARY Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment but come with the significant downside of immune-related adverse events (irAEs), which can...

$6.9M
USD
Active NON-SBIR/STTR RPGS
Spatially resolved multi-omics sequencing of FFPE tissues at cellular level
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2024 – 2027

Project Summary Studying tumors in a spatial context will advance our understanding of intratumoral heterogeneity and how the complex interactions between cancer and surrounding no...

$2.28M
USD
Active NON-SBIR/STTR RPGS
Pathways to Resilience of Social Networks of Older Adults with Advanced Cancer
NATIONAL CANCER INSTITUTE University of Rochester United States 2024 – 2029

Our study will address the goals of RFA-AG-24-025 by elucidating how the pathways by which key aspects of social connectedness in social networks (SNs)—structural characteristics,...

$7.5M
USD
Active NON-SBIR/STTR RPGS
COMBINATION HIGH-LET MOLECULAR RADIOTHERAPY OF RELAPSED REFRACTORY NEUROBLASTOMA
NATIONAL CANCER INSTITUTE Washington University United States 2024 – 2029

PROJECT SUMMARY There is a critical need for more effective treatments for metastatic and relapsed neuroblastoma (NB), the most commonly diagnosed extracranial solid cancer in chil...

$6M
USD
Completed SBIR-STTR RPGS
Development of a novel pan-cancer CAR-T product against AML and Glioblastoma
NATIONAL CANCER INSTITUTE Kure. Ai, Inc United States 2024 – 2025

Despite therapeutic advances outcomes are still poor for patients with most relapsed/refractory malignancies. Recently CAR-T cell therapies have demonstrated significant potential...

$4M
USD
Active NON-SBIR/STTR RPGS
Determining the Feasibility of Virtual Tailored, Music-Based Relaxation for Anxiety Among Adolescent and Young Adult Cancer Survivors.
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2027

Clinical Problem: Up to 48.5% of adolescent and young adult (AYA, 15 – 39-years old) cancer survivors experience clinically relevant anxiety. Anxiety disrupts the successful achiev...

$3.01M
USD
Active NON-SBIR/STTR RPGS
Research Capacity Building by a Clinician Scientist within the Michigan Cancer Research Consortium- National Community Oncology Research Program
NATIONAL CANCER INSTITUTE Saint Joseph Mercy Health System United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT This Clinician Scientist project is proposed by Elie Dib, MD, MS, FACP, a member of the Michigan Cancer Research Consortium (MCRC)-National Community Oncol...

$1.13M
USD
Active NON-SBIR/STTR RPGS
Multimodal AI Fusion Model for Early Detection for Pancreatic Cancer
NATIONAL CANCER INSTITUTE Mayo Clinic Arizona United States 2024 – 2029

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDAC), accounting for 90% of all pancreatic cancers, is among the deadliest, due largely to late-stage diagnosis and the aggressiv...

$6M
USD
Active RESEARCH CENTERS
Addressing cancer disparities in Nigeria through Immuno-oncology Research – The NOLA Program
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2026

PROJECT SUMMARY – OVERALL In the US and other high-income countries, immunotherapy is transforming the management of some cancers, including colorectal cancer (CRC). However, immun...

$3.83M
USD
Active RESEARCH CENTERS
Administrative Core
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT – ADMINISTRATIVE CORE The Administrative Core of the Nigerian Immuno-Oncology Research (NOLA) program will provide centralized scientific leadership, exper...

Active RESEARCH CENTERS
Research Project
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT – RESEARCH PROJECT Outcomes for cancer patients in low- and middle-income countries (LMIC) like Nigeria are poor compared to high-income countries (HIC). A...

Completed SBIR-STTR RPGS
A Dose Expansion Study of SX-682 Alone and in Combination with Decitabine in MDS Patients
NATIONAL CANCER INSTITUTE Syntrix Biosystems, Inc United States 2024 – 2025

Myelodysplastic syndromes (MDS) are genetically and morphologically diverse hematopoietic neoplasms that arise from a small pool of mutant clones within hematopoietic stem and prog...

$4M
USD
Active NON-SBIR/STTR RPGS
National and Institutional Leadership and Support of NCI-Sponsored Clinical Trial Research as a Surgical Oncologist
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2024 – 2029

Project Summary: Dr. Akhil Chawla plays a pivotal role in the NCI clinical trials program at Northwestern University Robert H. Lurie Comprehensive Cancer Center (RHLCCC). As a Surg...

$905.4K
USD
Active NON-SBIR/STTR RPGS
A SYSTEMS THEORY APPROACH TO THE STUDY OF COLON AND LUNG CANCER HEALTH DISPARITIES USING NOVEL DATA LINKAGES
NATIONAL CANCER INSTITUTE University of South Carolina At Columbia United States 2024 – 2029

Abstract We will conduct innovative linkages between our state cancer registry, all-payer claims data, and mental health treatment sources from the South Carolina Integrated Data W...

$3.34M
USD